Cynthia Sirard - HeathCare Pharmaceuticals, Inc

基本信息

浏览量：29

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 73 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Phase 1/2 Multicenter Trial of DKN-01 As Monotherapy or in Combination with Docetaxel for the Treatment of Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

David R. Wise,Russell K. Pachynski,Samuel R. Denmeade,Rahul R. Aggarwal,Jiehui Deng,Victor Adorno Febles,Arjun V. Balar,Minas P. Economides,Cynthia Loomis,Shanmugapriya Selvaraj,Michael Haas,Michael H. Kagey,Walter Newman,Jason Baum,Andrea B. Troxel, Sarah Griglun,Dayna Leis, Nina Yang, Viktoriya Aranchiy,Sabrina Machado, Erika Waalkes, Gabrielle Gargano, Nadia Soamchand,Amrutesh Puranik,Pratip Chattopadhyay, Ezeddin Fedal,Fang-Ming Deng,Qinghu Ren,Luis Chiriboga,Jonathan Melamed,Cynthia A. Sirard,Kwok-Kin Wong

PROSTATE CANCER AND PROSTATIC DISEASES (2024)

引用0浏览0WOSNATURE引用

A Phase 2 Study (distinguish) of DKN-01 in Combination with Tislelizumab + Chemotherapy As First-Line (1L) Therapy in Patients with Advanced Gastric or GEJ Adenocarcinoma (GEA)

Samuel J. Klempner, Bassam,Zev A. Wainberg,Hope Elizabeth Uronis,Vi Kien Chiu,Aaron James Scott,Syma Iqbal,Mohamedtaki Abdulaziz Tejani, Melissa C. Stilian, Mathis Thoma,Michael Kagey,Jason Baum,Cynthia A. Sirard,Rachel A. Altura,Jaffer A. Ajani

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Methods and Tables S1-S3 from Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer

Lipika Goyal,Cynthia Sirard, Michael Schrag,Michael H. Kagey,Jennifer R. Eads,Stacey Stein,Anthony B. El-Khoueiry,Gulam A. Manji, Thomas A. Abrams,Alok A. Khorana,Rebecca Miksad,Devalingam Mahalingam,Andrew X. Zhu,Dan G. Duda

crossref（2023）

引用0浏览0引用

Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab As Second-Line Treatment of Advanced Colorectal Cancer (Defiance)

Zev A. Wainberg,Ralph V. Boccia,John H. Strickler,Markus H. Moehler,Cynthia A. Sirard,Erin K. Walsh,Elizabeth C. Parker,Keun-Wook Lee

Journal of clinical oncologyno. 4_suppl (2023): TPS275-TPS275

引用0浏览0引用

DKN-01 and tislelizumab plus chemotherapy as first-line (1L) investigational therapy in advanced gastroesophageal adenocarcinoma (GEA): DisTinGuish trial

S. J. Klempner,J. Chao,H. Uronis,C. Sirard,M. Kagey,J. Baum, J. Song,J. Wang,M. B. Sonbol,Z. A. Wainberg,J. A. Ajani

ANNALS OF ONCOLOGY（2022）

引用0浏览0引用

1213P DKN-01 and Tislelizumab + Chemotherapy As First-Line (1L) Investigational Therapy in Advanced Gastroesophageal Adenocarcinoma (GEA): DisTinGuish Trial

S.J. Klempner, Jianfei Chao,Hope E. Uronis,C. Sirard,M. Kagey,J. Baum, Jianyin Song,J. Wang, Mohamad Bassam Sonbol,Zev A. Wainberg,Jaffer A. Ajani

Annals of Oncology（2022）

引用4浏览0引用

553 DKN-01 and Tislelizumab As a Second-Line (2L) Investigational Therapy in Advanced DKK1 High Gastroesophageal Adenocarcinoma (GEA): DisTinGuish Trial

Samuel Klempner,Jaffer Ajani,Joseph Chao,Hope Uronis,Cynthia Sirard,Michael Kagey,Jason Baum,Lilin Zhang,In-Ho Kim,Do-Youn Oh,Byoung Yong Shim,Sun Jin Sym,Mohamad Sonbol,Mohamedtaki Tejani,Zev Wainberg,Devalingam Mahalingam,Keun-Wook Lee

Regular and Young Investigator Award Abstracts (2022)

引用0浏览0引用

1141 DKN-01 demonstrates immune modulatory activity and robust efficacy in colorectal cancer models

Michael Haas,Michael Kagey,Walter Newman,James Rottman,Milad Moloudizargari,Ajay Goel,Cynthia Sirard,Jason Baum

Regular and Young Investigator Award Abstracts（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn